Published in Clin Gastroenterol Hepatol on December 18, 2014
Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk. World J Hepatol (2015) 0.99
Amoxicillin-Clavulanate-Induced Liver Injury. Dig Dis Sci (2016) 0.80
Drug-induced liver injury: Do we know everything? World J Hepatol (2017) 0.75
Drug-induced Liver Injury: The Hepatic Pathologist's Approach. Gastroenterol Clin North Am (2017) 0.75
The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med (1992) 6.05
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology (2008) 5.45
Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology (2005) 3.52
Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf (2009) 3.48
Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology (2013) 2.72
Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology (2010) 2.30
The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis (2006) 2.27
Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl (2004) 1.96
Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking. Clin Exp Dermatol (2011) 1.76
Cephalexin-induced cholestatic hepatitis. J Clin Gastroenterol (2004) 1.66
A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. N Engl J Med (1990) 1.63
Drug-induced liver injury in a Swedish University hospital out-patient hepatology clinic. Aliment Pharmacol Ther (2006) 1.43
Guidelines for clinical care: anti-infective agents for intra-abdominal infection. A Surgical Infection Society policy statement. Arch Surg (1992) 1.34
Determinants of the clinical expression of amoxicillin-clavulanate hepatotoxicity: a prospective series from Spain. Hepatology (2006) 1.32
Third-generation cephalosporins. Med Clin North Am (1995) 1.11
Suspected drug-induced liver fatalities reported to the WHO database. Dig Liver Dis (2005) 1.09
Cefdinir-induced hepatotoxicity: potential hazards of inappropriate antibiotic use. J Gen Intern Med (2008) 1.06
Augmentation mammaplasty: postoperative cephalosporin-induced hepatitis. Plast Reconstr Surg (2007) 1.02
Cephalexin nephrotoxicity. Reversible nonoliguric acute renal failure and hepatotoxicity associated with cephalexin therapy. JAMA (1974) 0.94
Jaundice associated with cephalosporin therapy. Drug Intell Clin Pharm (1985) 0.92
Ceftriaxone-induced toxic hepatitis. World J Gastroenterol (2009) 0.91
Acute hepatitis, autoimmune hemolytic anemia, and erythroblastocytopenia induced by ceftriaxone. Am J Gastroenterol (1998) 0.86
Cephalosporin-induced cholestatic jaundice. Lancet (1982) 0.84
A rare case of hepatitis associated with cefprozil therapy. Scand J Infect Dis (2007) 0.83
Third generation cephalosporins. Infect Dis Clin North Am (1989) 0.82
Cholestatic hepatitis with intravenous ceftriaxone. Indian J Pharmacol (2011) 0.81
A fatal case of fulminant hepatic necrosis following sevoflurane anesthesia. Toxicol Pathol (2007) 0.80
Cephalosporins: rationale for clinical use. Am Fam Physician (1991) 0.80
First case of ivermectin-induced severe hepatitis. Trans R Soc Trop Med Hyg (2006) 0.79
Cefixime-induced hepatotoxicity. Turk J Gastroenterol (2011) 0.78
The selection and use of cephalosporins: a review. Adv Ther (1995) 0.77
Relationship between characteristics of medications and drug-induced liver disease phenotype and outcome. Clin Gastroenterol Hepatol (2013) 1.46
Under-reporting and Poor Adherence to Monitoring Guidelines for Severe Cases of Isoniazid Hepatotoxicity. Clin Gastroenterol Hepatol (2015) 1.43
Clinical and histologic features of azithromycin-induced liver injury. Clin Gastroenterol Hepatol (2014) 0.89
Features of Autoimmune Hepatitis in Patients With Drug-induced Liver Injury. Clin Gastroenterol Hepatol (2016) 0.84
Recombinant human factor VIIa for alveolar hemorrhage following allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2014) 0.82
High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery. Gastroenterology (2015) 0.81
Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults. Clin Infect Dis (2014) 0.81
Drug-induced nodular regenerative hyperplasia. Semin Liver Dis (2014) 0.78
Reply. Clin Gastroenterol Hepatol (2016) 0.75